Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-939-5 | CAS number: 933999-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study is peer-reviewed published. However, experiments were not conducted with GLP compliance.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Dermal penetration of skin samples determined by Franz cell technology with liquid scintillation counting and detection of radiolabeled metabolites by HPLC.
- GLP compliance:
- no
Test material
- Reference substance name:
- 2-({[6-({1-chloro-3-[(oxiran-2-yl)methoxy]propan-2-yl}oxy)hexyl]oxy}methyl)oxirane; 2-[({6-[(oxiran-2-yl)methoxy]hexyl}oxy)methyl]oxirane; 3-chloro-2-({6-[(oxiran-2-yl)methoxy]hexyl}oxy)propan-1-ol; 6-[(oxiran-2-yl)methoxy]hexan-1-ol
- EC Number:
- 618-939-5
- Cas Number:
- 933999-84-9
- Molecular formula:
- C6H14O2 + C3H5ClO
- IUPAC Name:
- 2-({[6-({1-chloro-3-[(oxiran-2-yl)methoxy]propan-2-yl}oxy)hexyl]oxy}methyl)oxirane; 2-[({6-[(oxiran-2-yl)methoxy]hexyl}oxy)methyl]oxirane; 3-chloro-2-({6-[(oxiran-2-yl)methoxy]hexyl}oxy)propan-1-ol; 6-[(oxiran-2-yl)methoxy]hexan-1-ol
- Details on test material:
- As per IUCLID5 Sections 1.1. - 1.4.
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- by 14-C epichlorohydrin
Test animals
- Species:
- other: rat, mouse and human skin in vitro.
- Strain:
- other: Fisher 344 rat and C3H mouse skin.
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Fisher rats (~ 250 gm) and C3H mice (~ 25 gm) were aquired from Central Laboratories for Blood Banks, Amserdam, The Netherlands. The animal room was maintained 22 +/- 2 degrees C and 60 +/- 15% relative humidity with a 12 hr light/dark cycle. A standard rodent diet and de-ionized water were supplied ad libitum.
Administration / exposure
- Type of coverage:
- other: occluded and nonoccluded
- Vehicle:
- acetone
- Duration of exposure:
- 24 hr
- Doses:
- 636 mM
- No. of animals per group:
- Three animals served as skin donors per dose point.
- Control animals:
- yes
- Remarks:
- for control skin.
- Details on study design:
- Fresh full-thickness healthy human breast skin was from five female Caucasian patients aged 17 - 41 years. The skin was maintained on ice following removal and transport to the laboratory where it was used within three hours of removal. The skin samples from rodents was used within two hours of removal. Excess subcutaneous tissue was removed fro the skin samples with a scalpel. The skin was placed on a dissecting board and full-thickness skin circles cut out using a circular steel cutter. Mouse skin was used full-thickness while rat and human skin samples were dermtomized. The skin samples were mounted epidermis side up in a flow-through diffusion cell system for the dermal penetration studies.
Results and discussion
- Signs and symptoms of toxicity:
- not specified
- Remarks:
- Study was in vitro.
- Dermal irritation:
- not specified
- Remarks:
- Study was in vitro.
- Absorption in different matrices:
- No data
- Total recovery:
- Based on mass balance total recovery was 83 - 90% depending on species.
Percutaneous absorptionopen allclose all
- Dose:
- 636 mM
- Parameter:
- percentage
- Absorption:
- ca. 37.8 %
- Remarks on result:
- other: 24 hr
- Remarks:
- human skin
- Dose:
- 636 mM
- Parameter:
- percentage
- Absorption:
- ca. 67.2 %
- Remarks on result:
- other: 24 hr
- Remarks:
- Rat skin
- Dose:
- 636 mM
- Parameter:
- percentage
- Absorption:
- ca. 80.3 %
- Remarks on result:
- other: 24 hr
- Remarks:
- Mouse skin
- Conversion factor human vs. animal skin:
- Approximately 2 to 4-fold less depending on species.
Any other information on results incl. tables
Permeability Constant (in 10 -6 cm/hr)
_____________________________________
Human skin 136 + 28
Rat Skin 402 + 22
Mouse Skin 577 + 86
Applicant's summary and conclusion
- Conclusions:
- The skin absorption/penetration of 1,6-Hexanediol Diglycidylether (HDDGE) based on in vitro measurment was approximately 2 to 4-fold less for human breast skin samples compared to rodent skin. In human skin, approximately 20% of the absorbed HDDGE is metabolised, primarily to the mono-diol metabolite.
- Executive summary:
1,6 -Hexanediol Diglycidylether (HDDGE) was evaluated for dermal absorption/penetration and metabolism using human, mouse and rat skin samples with diffusion cell in vitro technology and HPLC analysis. The skin absorption/penetration of HDDGE based on in vitro measurment was approximately 2 to 4-fold less for human breast skin samples compared to rodent skin. In human skin, approximately 20% of the absorbed HDDGE is metabolised, primarily to the mono-diol metabolite.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.